Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

AACR Cancer Progress Report 2015
José Baselga, Nina Bhardwaj, Lewis C. Cantley, et al.
Clinical Cancer Research (2015) Vol. 21, Iss. 19_Supplement, pp. S1-S128
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases
Asghar Fallah, Ali Sadeghinia, Houman Kahroba, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 110, pp. 775-785
Open Access | Times Cited: 216
Insights into the activation mechanism of class I HDAC complexes by inositol phosphates
Peter J. Watson, Christopher J. Millard, Andrew M. Riley, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 215
Computational models for predicting drug responses in cancer research
Francisco Azuaje
Briefings in Bioinformatics (2016), pp. bbw065-bbw065
Open Access | Times Cited: 172
Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward
Amila K. Nanayakkara, Helen W. Boucher, Vance G. Fowler, et al.
CA A Cancer Journal for Clinicians (2021) Vol. 71, Iss. 6, pp. 488-504
Open Access | Times Cited: 137
From Bioinspired Glue to Medicine: Polydopamine as a Biomedical Material
Daniel Hauser, Dedy Septiadi, Joel G. Turner, et al.
Materials (2020) Vol. 13, Iss. 7, pp. 1730-1730
Open Access | Times Cited: 86
The Efficacy of Immune Checkpoint Inhibitors in Microsatellite Stable Colorectal Cancer: A Systematic Review
Deniz Can Güven, Gözde Kavgacı, Enes Erul, et al.
The Oncologist (2024) Vol. 29, Iss. 5, pp. e580-e600
Open Access | Times Cited: 10
Biomarkers of response to immune checkpoint blockade in cancer treatment
Takeo Fujii, Aung Naing, Christian Rolfo, et al.
Critical Reviews in Oncology/Hematology (2018) Vol. 130, pp. 108-120
Closed Access | Times Cited: 72
Costimulatory Molecules and Immune Checkpoints Are Differentially Expressed on Different Subsets of Dendritic Cells
Claudia Carenza, Francesca Calcaterra, Ferdinando Oriolo, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 71
Cellular immunotherapies for cancer
Conall Hayes
Irish Journal of Medical Science (1971 -) (2020) Vol. 190, Iss. 1, pp. 41-57
Open Access | Times Cited: 69
Discovery of new 3-methylquinoxalines as potential anti-cancer agents and apoptosis inducers targeting VEGFR-2: design, synthesis, and in silico studies
Mohammed M. Alanazi, Alaa Elwan, Nawaf A. Alsaif, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1732-1750
Open Access | Times Cited: 44
Anticancer potential of ferrocene-containing derivatives: Current and future prospective
Vijesh Tomar, Parveen Kumar, Deepak Sharma, et al.
Journal of Molecular Structure (2024) Vol. 1319, pp. 139589-139589
Closed Access | Times Cited: 8
1,3,4-Oxadiazole-naphthalene hybrids as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative activity, apoptotic effect, and in silico studies
Mohamed Hagras, Marwa A. Saleh, Rogy R. Ezz Eldin, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 37, Iss. 1, pp. 386-402
Open Access | Times Cited: 36
There Is Something Fishy About Liver Cancer: Zebrafish Models of Hepatocellular Carcinoma
Paul J. Wrighton, Isaac M. Oderberg, Wolfram Goessling
Cellular and Molecular Gastroenterology and Hepatology (2019) Vol. 8, Iss. 3, pp. 347-363
Open Access | Times Cited: 43
Impact of the Human Microbiome in Forensic Sciences: a Systematic Review
Manuel Romana García, María D. Pérez-Cárceles, Eduardo Osuna, et al.
Applied and Environmental Microbiology (2020) Vol. 86, Iss. 22
Open Access | Times Cited: 39
Discovery and Characterization of XY101, a Potent, Selective, and Orally Bioavailable RORγ Inverse Agonist for Treatment of Castration-Resistant Prostate Cancer
Yan Zhang, Xishan Wu, Xiaoqian Xue, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 9, pp. 4716-4730
Closed Access | Times Cited: 37
Gasotransmitters in the tumor microenvironment: Impacts on cancer chemotherapy (Review)
Abbas Salihi, Mohammed Ali Al-Naqshabandi, Zhikal Omar Khudhur, et al.
Molecular Medicine Reports (2022) Vol. 26, Iss. 1
Open Access | Times Cited: 20
AACR Cancer Progress Report 2016
Nancy E. Davidson, Scott A. Armstrong, Lisa M. Coussens, et al.
Clinical Cancer Research (2016) Vol. 22, Iss. 19_Supplement, pp. S1-S137
Closed Access | Times Cited: 34
miR‑425‑5p is associated with poor prognosis in patients with breast cancer and promotes cancer cell progression by targeting PTEN
Sheng Xiao, Hongjia Zhu, Jian Luo, et al.
Oncology Reports (2019)
Open Access | Times Cited: 34
The Functional Role of Long Non-coding RNA UCA1 in Human Multiple Cancers: a Review Study
Nashmin Fayazi Hosseini, Hamed Manoochehri, Saeideh Gholamzadeh Khoei, et al.
Current Molecular Medicine (2020) Vol. 21, Iss. 2, pp. 96-110
Closed Access | Times Cited: 29
Agrimol B present in Agrimonia pilosa Ledeb impedes cell cycle progression of cancer cells through G0 state arrest
Su Su Thae Hnit, Rongzhen Ding, Ling Bi, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111795-111795
Open Access | Times Cited: 27
2D and 3D-QSAR Modeling of 1H‑Pyrazole Derivatives as EGFR Inhibitors: Molecular Docking, and Pharmacokinetic Profiling
Sagiru Hamza Abdullahi, Adamu Uzairu, Gideon Adamu Shallangwa, et al.
Chemistry Africa (2023) Vol. 6, Iss. 3, pp. 1381-1398
Closed Access | Times Cited: 8
Feedback activation of AMPK-mediated autophagy acceleration is a key resistance mechanism against SCD1 inhibitor-induced cell growth inhibition
Akito Ono, Osamu Sano, Ken‐ichi Kazetani, et al.
PLoS ONE (2017) Vol. 12, Iss. 7, pp. e0181243-e0181243
Open Access | Times Cited: 24
Ras-Mediated Activation of NF-κB and DNA Damage Response in Carcinogenesis
Anas Ahmad, Haseeb Ahsan
Cancer Investigation (2020) Vol. 38, Iss. 4, pp. 185-208
Closed Access | Times Cited: 20
Solving operational problems in outpatient chemotherapy clinics using mathematical programming and simulation
Mahmoud Heshmat, Amr Eltawil
Annals of Operations Research (2019) Vol. 298, Iss. 1-2, pp. 289-306
Closed Access | Times Cited: 19
Role of BET proteins in castration-resistant prostate cancer
Ester Fernández‐Salas, Shaomeng Wang, Arul M. Chinnaiyan
Drug Discovery Today Technologies (2016) Vol. 19, pp. 29-38
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top